FIELD: chemistry.
SUBSTANCE: present invention relates to compounds characterised by formula I, and their use as sodium and/or calcium channel modulators when treating a wide range of diseases, including cardio-vascular, inflammatory, eye, urological, metabolic and gastro-intestinal diseases, as sell as a method of producing formula I compounds and pharmaceutical compositions based on formula I compounds. , where m equals 1-3, X is -CH2-, O, S or NR6; R1 is a possibly substituted alkyl, alkenyl or alkynyl, phenyl, benzyl, phenoxy or naphthyl; R2, R3 represent hydrogen, alkyl, halogen, trifluoromethyl, hydroxy or alkoxy; R4, R5, R6 represent hydrogen or alkyl.
EFFECT: obtaining of novel biologically active compounds and pharmaceutical compositions based on the said compounds.
7 cl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
N-ACYL-N' -BENZYLALYLENEDIAMNO DERIVATIVES | 2004 |
|
RU2387636C2 |
N-SUBSTITUTED ADENINE-BASED HETEROCYCLIC COMPOUNDS, THEIR USE IN PRODUCTION OF MEDICAMENTS, COSMETICS, GROWTH REGULATORS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS OR GROWTH REGULATORS BASED THEREON | 2002 |
|
RU2302421C2 |
PYRROLO[3,2-b]PYRIDINE DERIVATIVES AND METHOD OF PRODUCING SAID DERIVATIVES | 2005 |
|
RU2397170C2 |
NEW ESTERS OF HYDROXIMIC ACIDS AND THEIR PHARMACEUTICAL APPLICATION | 2004 |
|
RU2357952C2 |
CYCLOPENTYL DERIVATIVES | 2004 |
|
RU2372325C2 |
0 |
|
SU528866A3 | |
0 |
|
SU527134A3 | |
SUBSTITUTED PIPERIDINES AS NEW MDM2-p53 INHIBITORS | 2004 |
|
RU2333201C2 |
0 |
|
SU523634A3 | |
METHOD OF OBTAINING BENZYLAMINE DERIVATIVES OR SALTS THEREOF | 0 |
|
SU640657A3 |
Authors
Dates
2010-07-27—Published
2004-11-16—Filed